from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3364c/-

LFCtreatmentdescriptionclass of inhibitor

-1.614

Amikacinug/mL Amikacintranslation

-1.573

Cap5-10ug/mL Capreomycintranslation

-1.779

Rox10-50 ug/mL Roxithromycintranslation

-0.935

SM2-5 ug/mL Streptomycintranslation

-1.439

Tet5-10 ug/mL Tetracyclinetranslation

-0.139

Rif0.2-5ug/mL Rifampicintranscription

-0.460

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.639

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.164

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.005

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.653

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.964

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.614

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.843

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.694

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.754

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.473

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.120

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.038

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.765

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.656

KCN5-20 ug/mL Potassium cyaniderespiration

0.301

NaN30.2-2 mM Sodium aziderespiration

-0.064

Nigericin50 uM Nigericinrespiration

0.267

TRC10-150 ug/mL Triclosanrespiration

0.385

TRZ10-25 ug/mL Thioridazinerespiration

-1.031

Valinomycin0.5-10 uM Valinomycinrespiration

-1.779

ZnSO42 mM ZnSO4respiration

1.120

menadione6-10 ug/mL Menadionerespiration

-0.086

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.171

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.529

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.252

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.326

NRP_1Non-replicating persistence stage 1dosRassociated

0.105

Amp0.2mg/mL AmpicillincellWall

-0.583

Cephalexin20-100 ug/mL CephalexincellWall

-0.596

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.209

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.157

EMB10-20 ug/mL EthambutolcellWall

-1.569

Eta12-40 ug/mL EthionamidecellWall

-1.696

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.027

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.809

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.459

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.709

BZA0.12 mg/mL BenzamidearomaticAmides

0.235

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.082

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.194

H2O24 mM hydrogen peroxideDNAdamaging

-0.388

Levo10 ug/mL LevofloxacinDNAdamaging

0.465

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.765

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.257

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.244

UVUV-irradiationDNAdamaging

0.674

ARP41-4 ug/mL Antitubercular compound ARP4?

0.273

Antimycin12.5-50 ug/mL Antimycin A?

0.078

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.263

PA_110-50 ug/mL Antitubercular compound PA-1?

0.112

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.740

PA8240.2-2 ug/mL PA-824?

0.061

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.020

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.019

Verapamil50 uM Verapamil?

-0.140

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.174

methoxatin10-20 ug/mL Methoxatin?